Prognostic Value of Pretreatment Systemic Immune-Inflammation Index in Glioblastoma Multiforme Patients Undergoing Postneurosurgical Radiotherapy Plus Concurrent and Adjuvant Temozolomide - Concepedia

Concepedia

Publication | Open Access

Prognostic Value of Pretreatment Systemic Immune-Inflammation Index in Glioblastoma Multiforme Patients Undergoing Postneurosurgical Radiotherapy Plus Concurrent and Adjuvant Temozolomide

DOI Full Paper Access

23

Citations

23

References

2020

Year

Erkan Topkan, Ali Ayberk Beşen, Yurday Özdemir, Ahmet Küçük, Hüseyin Mertsoylu, Berrin Pehlivan, Uğur Selek

Mediators of Inflammation

Abstract

The outcomes displayed here qualified the pretreatment SII as a novel independent prognostic index for predicting survival outcomes of newly diagnosed GBM patients undergoing postneurosurgical radiotherapy and concurrent plus adjuvant temozolomide.

References

	Year	Citations

Page 1